Company Badge
USPTO Data Jan 1 1976 - Oct 6 2026
11 Patents
#406 in San Francisco, CA
#6,532 in California
#27,490 in US
#51,714 in the World
Prosetta Antiviral, Inc.
Forward Citations = 12
13 inventors:
San Francisco, CA, United States of America
Prosetta Antiviral, Inc.
% Expired Patents = 36.4
CIPO Patents = 1
EPO Patents = 3
Forward Citations = 12
Loading Chart...
Loading Chart...
13 inventors (with patents filed for the assignee):
Clarence R Hurt (8 out of 9 patents)
Vishwanath R Lingappa (8 out of 18 patents)
Andy Atuegbu (6 out of 14 patents)
4. Anatoliy Kitaygorodskyy (5 out of 6 patents)
5. Beverly Freeman (5 out of 5 patents)
6. Dennis Solas (2 out of 47 patents)
7. Jacob J Plattner (1 out of 105 patents)
8. Suganya Selvarajah (1 out of 1 patent)
9. Kumar Paulvannan (1 out of 2 patents)
10. Debendranath Dey (1 out of 1 patent)
11. Anatoliy Kitaygorodorskyy (1 out of 1 patent)
12. Colm Kelleher (1 out of 1 patent)
13. William Hansen (1 out of 1 patent)
14. Anatoliy Kityagorodskyy (0 patent)
11 patents:
Prosetta Antiviral, Inc. is a biotechnology company based in San Francisco, California, specializing in the development of innovative antiviral therapies. The organization focuses on addressing viral infections through advanced research and technology, leveraging its expertise in molecular biology and drug discovery. Prosetta aims to create effective treatments that target a range of viral pathogens, contributing to global health solutions and enhancing therapeutic options in the field of infectious diseases.
Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
1 patent (CIPO):
Please report any incorrect information to [email protected]
3 patents (EPO):
Please report any incorrect information to [email protected]